日照癫痫病医院公立河南哪里医院看羊癫疯好,江苏癫痫医院要多少钱,潍坊到哪治疗癫痫医院好,安徽癫痫专科医院在哪,东营治疗癫痫病的新方法,泰安羊羔疯病医院,泰安那里治疗痫病

SAN FRANCISCO, May 6 (Xinhua) -- Bud Tribble, Apple's vice president of software technology, will testify at the Congressional hearings on mobile privacy next week, according to the witness list released on Friday.Tribble will represent Apple at the hearings of the U.S. Senate Judiciary Subcommittee on Privacy, Technology and the Law. The hearings, entitled "Protecting Mobile Privacy: Your Smartphones, Tablets, Cell Phones and Your Privacy," is scheduled to take place next Tuesday in the wake of an iPhone location database controversy.Tribble is one of the industry's top experts in software design and object-oriented programming, known for helping to design the Mac OS and user interface. He is considered as the right-hand man of Apple CEO Steve Jobs and has been with Jobs since they developed the original Macintosh. When Jobs was forced to resign from Apple in 1985, Tribble followed Jobs and co-founded another computer company NeXT Computer. He rejoined Apple and Jobs in 2002.At the upcoming Congressional hearing, Tribble will be joined by Alan Davidson, Google's director of public policy for the Americas.Apple has been under heavy fire after it was alleged last month that its iphones and other smart phones had been collecting customers' location information. In the wake of the controversy, U. S. senator Al Franken, chairman of the Senate Judiciary Subcommittee on Privacy, Technology and the Law, scheduled the mobile privacy hearing and asked representatives from Apple and Google to testify.Apple has denied the alleged practice and released software updates to make iPhone store less location information to quell public concerns over privacy.

LOS ANGELES, May 1 (Xinhua) -- Middle-aged adults who sleep too less or too much may be more likely to suffer cognitive decline, a new study suggests.According to the study, less than six hours of sleep each night is considered too little and more than eight hours as too much for middle-aged adults.The study, conducted by researchers at University College London Medical School, was published May 1 in the American medical journal Sleep.The researchers conducted the study in two periods -- the 1997- 1999 period and the 2003-2004 period. The participants were asked how many hours they slept on an average week night, and were asked the same question in 2003-2004 after an average 5.4 years of follow-up.The researchers compared those who reported changes in their sleep patterns with people whose sleep duration stayed the same over the course of the study.In the follow-up, each individual was given a battery of standard tests to assess his or her memory, reasoning, vocabulary, global cognitive status and verbal fluency.The study findings show that women who slept seven hours per night had the highest score for every cognitive measure, followed by those who had six hours of sleep. For men, cognitive function was similar for those who reported sleeping six, seven or eight hours.However, less than six hours of sleep -- or more than eight hours -- were associated with lower scores."Sleep provides the body with its daily need for physiological restitution and recovery," explained Jane Ferrie, a senior research fellow in the department of epidemiology and public health at the school. "While seven hours a night appears to be optimal for the majority of human beings, many people can function perfectly well on regular sleep of less or more hours."However, since most research has focused on the effects of sleep deprivation on biological systems, it is not yet fully understood why seven hours is optimal -- or why long sleeping appears to be detrimental, Ferrie said."Chronic short sleep produces hormones and chemicals in the body which increase the risk of developing heart disease and strokes, and other conditions like high blood pressure and cholesterol, diabetes and obesity," she added.

WASHINGTON, March 22 (Xinhua) -- A long-term study by Greek researchers has shown the effectiveness of replacing bone marrow, purposely destroyed by chemotherapy, with autologous (self) stem cells in treating people with aggressive forms of multiple sclerosis (MS).The study was published on Tuesday in Neurology, the medical journal of the American Academy of Neurology.For the treatment, chemotherapy drugs are used to kill all of the patient's blood cells, including the immune cells that are believed to be attacking the body's own central nervous system. Bone marrow stem cells removed from the patient are purified and transplanted back into the body, which saves life by replacing the blood cells and also is proposed to "reboot" the immune system.A human embryonic stem cell line derived at Stanford University is seen in this handout photo released to Reuters by the California Institute for Regenerative Medicine, March 9, 2009The study followed 35 people for an average of 11 years after transplant. The study involved people with rapidly progressive MS who had tried a number of other treatments for MS with little or no effect. All were severely disabled by the disease, with an average score of six on a scale of disease activity that ranges from zero being a normal neurological examination to 10 meaning death due to MS.A score of six means able to walk with a cane or crutch; a seven is mainly in a wheelchair. All had worsened by at least one point on the scale in the year prior to the transplant.After the transplants, the probability of participants having no worsening of their disease for 15 years was 25 percent. The probability was higher -- 44 percent -- for those who had active brain lesions, which are a sign of disease activity, at the time of the transplant.For 16 people, symptoms improved by an average of one point on the scale after the transplant, and the improvements lasted for an average of two years. The participants also had a reduction in the number and size of lesions in their brains. Two people (six percent) died from complications related to the transplant at two months and 2-1/2 years post-transplant.Study author Vasilios Kimiskidis, of Aristotle University in Thessaloniki, Greece, noted that more research is needed on this treatment, including studies that compare people receiving the treatment to a control group that does not receive the treatment."Keeping that in mind, our feeling is that stem cell transplants may benefit people with rapidly progressive MS," he said. "This is not a therapy for the general population of people with MS but should be reserved for aggressive cases that are still in the inflammatory phase of the disease."

BEIJING, March 19 (Xinhua) -- Radiation leaks following explosions at the Fukushima Daiichi nuclear power plant in Japan will not affect China's environment and the health of its citizens during the next three days, authorities said Saturday.China's National Nuclear Emergency Coordination Committee made the announcement based upon analyses of environmental monitoring, meteorological forecasts, and ocean currents.The Beijing-based Regional Specialized Meteorological Center, which is affiliated with the World Meteorological Organization, issued its forecast on Saturday afternoon, saying that the radioactive leakages in Japan would not affect China over the next three days.The country's State Oceanic Administration on Saturday announced that no abnormalities were detected in terms of atmospheric radiation over the East China Sea, the northern part of the South China Sea, and the central and northern regions of the Yellow Sea.The administration predicts that the ocean currents near Fukushima would mainly travel eastward from Japan over the next three days.Furthermore, the country's Ministry of Environmental Protection announced that China's environment remains normal based upon the monitoring of radiation levels.

BEIJING, March 15 (Xinhuanet) --After one-year effort of developing, Microsoft is going to release its newest web browser Internet Explorer 9 at 9:00 p.m. Pacific time on Monday, according to media reports.The IE 9 will be the first major Web browser to include a do-not-track tool that helps people keep their online habits from being monitored, which makes Google Inc. and Apple Inc. the only big providers of browsers that haven't yet declared their support for a do-no-track system in their products.IE 9 can work on computers running Windows Vista and Windows 7 operating systems, but not compatible with Windows XP.This final release-to-Web version of IE 9 represents the ninth release since the first platform preview of the browser appeared at the MIX 10 Web developer event, said Ryan Gavin, the senior director of Internet Explorer business and marketing. Gavin pointed out that the browser has already made its mark in Microsoft's download history."We're seeing now upwards of two percent share already on Windows 7 for IE 9, even in beta stage. It was the fastest adopted beta ever in Microsoft's history," he said.IE 9 is being launched as part of the South by Southwest event currently taking place in Austin, Texas.